Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal

Autor: Alioune Dieye, Seydi Abdoul Ba, Doudou Diouf, Philomène Lopez Sall, Hagay Sobol, Serigne Modou Kane Gueye, Violaine Bourdon-Huguenin, Mamadou Moustapha Dieng, Ahmadou Dem, Babacar Mbengue, Sidy Ka, Oumar Faye, Aynina Cisse, Pape Saloum Diop, Papa Madieye Gueye, Jean Pascal Demba Diop, Maguette Sylla Niang, Ndiaye R, Yacouba Dia, Thiam A, Papa Amadou Diop
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: npj Genomic Medicine, Vol 5, Iss 1, Pp 1-6 (2020)
NPJ Genomic Medicine
ISSN: 2056-7944
Popis: BRCA1 and BRCA2 are the most incriminated genes in inherited breast/ovarian cancers. Several pathogenic variants of these genes conferring genetic predisposition have been described in different populations but rarely in sub-Saharan Africa. The objectives of this study were to identify pathogenic variants of the BRCA genes involved in hereditary breast cancer in Senegal and to search for a founder effect. We recruited after free informed consent, 27 unrelated index cases diagnosed with breast cancer and each having a family history. Mutation screening of the genes identified a duplication of ten nucleotides c.815_824dupAGCCATGTGG, (p.Thr276Alafs) (NM_007294.3) located in exon 11 of BRCA1 gene, in 15 index cases (allelic frequency 27.7%). The pathogenic variant has been previously reported in African Americans as a founder mutation of West African origin. Haplotypes analysis of seven microsatellites surrounding the BRCA1 gene highlights a shared haplotype encompassing ~400 kb between D17S855 and D17S1325. This haplotype was not detected in none of 15 healthy controls. Estimation of the age of the pathogenic variant suggested that it occurred ~1400 years ago. Our study identified a founder pathogenic variant of BRCA1 predisposing to breast cancer and enabled the establishment of an affordable genetic test as a mean of prevention for Senegalese women at risk.
Databáze: OpenAIRE